Fig. 3
Survival analysis of NCAPD2 in pan-cancer. (A) The OS of patients with NCAPD2. (B) The DFS of patients with NCAPD2. (C) The survival of patients with NCAPD2 in breast, ovarian, gastric, lung and liver cancer (all P < 0.05)
Fig. 3 | Genes and Environment